Intel Shares Plunge 5% as Political Criticism and Foundry Legal Woes Blunt CPU Rally
Intel (INTC) shares are retreating 4.92% to $44.86 on Thursday morning, erasing much of the momentum from a massive mid-week rally. The sharp reversal follows a combination of high-profile political criticism directed at the company's leadership and a fresh patent lawsuit targeting a key foundry partner, prompting investors to lock in profits after yesterday's euphoria over CPU price hikes.
Reversal After Price Hike Euphoria
Intel's slide on Thursday represents a stark about-face from Wednesday's session, where the stock surged nearly 8% following reports that the company intended to raise CPU prices by 10% to 15%. That move, coupled with the official launch of the Core Ultra Series 3 processors built on the advanced 18A process node, had briefly convinced markets that Intel was regaining its footing in the high-stakes semiconductor landscape. However, the intraday drop to $44.86 suggests that the 'turnaround story' remains fragile, as the stock hit a wall of technical resistance near the consensus analyst price target of $45.74.
Political and Legal Headwinds
The primary catalyst for today's acceleration to the downside appears to be a dual blow of political and legal uncertainty. Early Thursday morning, reports surfaced that President Trump publicly criticized Intel CEO Lip-Bu Tan, questioning the company's strategic direction and suggesting it might be time for investors to 'dump' the stock. This political meddling has introduced a layer of sentiment risk that often outweighs fundamental improvements in the chip sector, particularly for a company so heavily tied to domestic manufacturing subsidies and the CHIPS Act.
Simultaneously, the semiconductor ecosystem was rattled by news that GlobalFoundries (GFS) filed multiple patent infringement lawsuits against Tower Semiconductor. While Intel's previous attempt to acquire Tower was called off in 2023, the two companies maintain a deep foundry partnership. The litigation, filed in the U.S. International Trade Commission, alleges that Tower is 'freeriding' on GlobalFoundries' research and development. For Intel, which is betting its entire future on becoming a world-class foundry, any legal instability involving its manufacturing partners is viewed as a threat to its 2026 and 2027 execution milestones.
Foundry Execution and Valuation Caps
Despite the recent product launches, Intel's underlying financials continue to weigh on the narrative. The company’s Foundry segment posted a staggering $2.51 billion operating loss in the fourth quarter of 2025, and management has guided for zero non-GAAP earnings per share in the current quarter. Analysts at firms like HSBC and Bank of America have maintained 'Reduce' or 'Underperform' ratings, citing the capital-intensive nature of the 18A and 14A node buildouts.
With the stock trading down 4.92% on volume of 29.5 million shares, it is significantly underperforming the broader S&P 500, which is down a more modest 0.82%. Investors appear to be reassessing whether the 10-15% price hikes will be enough to offset the massive capital expenditures required to keep the foundry dream alive, especially as competitors like AMD continue to gain share in the lucrative data center market. Looking ahead, the market will be laser-focused on whether Intel can secure a major external customer for its 18A node to justify the ongoing manufacturing losses.
Key Takeaways
- Intel shares fell 4.92% to $44.86, reversing a rally driven by 10-15% CPU price hike announcements.
- Presidential criticism of CEO Lip-Bu Tan introduced significant political sentiment risk early in the session.
- A patent lawsuit by GlobalFoundries against Intel partner Tower Semiconductor has raised concerns about foundry execution.
- The stock faced technical resistance after hitting the consensus analyst price target of $45.74.